Marketer with over 20 years of experience selected to head up marketing at Predictive Oncology
April 26, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., April 26, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced that Theresa Ferguson has been named Senior Director of Marketing. As Predictive Oncology’s senior...
Predictive Oncology Reports Year End 2021 Financial Results and Provides Business Update
March 31, 2022 17:25 ET
|
Predictive Oncology Inc.
EAGAN, Minn., March 31, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology validates Discovery 21 proof-of-concept campaign
March 24, 2022 08:30 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, March 24, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) achieved a key milestone toward monetizing its unique approach to leverage artificial intelligence (AI) in oncology...
Predictive Oncology set to market AI drug discovery platform
January 27, 2022 07:30 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) is set to be a first mover in the artificial intelligence (AI) powered drug discovery market that POAI expects...
POAI Reports Strong Results From Its AI Cancer Drug Evaluation
January 13, 2022 08:30 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) reported the preliminary results of its Discovery 2021 program today, announcing that its Helomics subsidiary’s...
Predictive Oncology Adjourns Annual Meeting of Stockholders to December 30, 2021
December 27, 2021 17:10 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology – Year-end Shareholder Update!
December 21, 2021 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, is...
Pamela Bush, Ph.D., MBA, Joins Predictive Oncology as SVP of Strategic Sales and Business Development
December 07, 2021 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies,...
Predictive Oncology Acquires zPREDICTA, Inc.
December 01, 2021 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies,...
Predictive Oncology Reports Third Quarter Financial Results
November 10, 2021 17:15 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Results from the third quarter show strong potential for future growth, said Predictive Oncology (Nasdaq: POAI) today, announcing financial results...